DeepScribe vs Suki (2026)
This pairing separates two different ideas of what comes after the scribe. DeepScribe went deep: built for complex specialty medicine with oncology as its center of gravity, a reported 5 million oncology visits a year and roughly 40 percent of US cancer care visits documented on the platform, holding a 98.8 KLAS Emerging Company Spotlight score with A plus marks in all six categories, the highest independent rating in the lane. Suki went interactive: a voice first assistant where ambient capture sits alongside commands that operate the EHR itself, ordering medications, navigating charts, querying the record, and staging orders for review, across deep bidirectional integrations from Epic to MEDITECH. If your failure mode is specialty documentation that generic scribes get wrong, oncology above all, start with DeepScribe. If your failure mode is the clicks around the note rather than the note itself, start with Suki. Neither publishes pricing.
- Specialty depth is the requirement: tuned models for oncology, cardiology, urology, gastroenterology, orthopedics, neurology, and nephrology, with a reported 40 percent of US cancer care visits documented on the platform.
- The independent rating is the strongest in the lane: a 98.8 KLAS Emerging Company Spotlight score with A plus marks across all six measured categories, plus 2025 KLAS Top 5 rankings for outcomes, patient experience, and clinician experience.
- Chart aware in both directions: bidirectional integration with Epic, athenahealth, NextGen, and eClinicalWorks reads context before the visit and writes structured data into discrete fields after, with HCC, CPT, and ICD-10 suggestions built into the note.
- You want to operate the EHR by voice, not just document: commands order medications, navigate charts, query the patient record, stage orders for review, and pull schedules, which no passive scribe does.
- EHR reach across mixed estates: deep bidirectional integrations with Epic, Oracle Health, athenahealth, MEDITECH, and Elation, plus a partnership program extending to further systems.
- You build healthcare software: Suki Platform lets other vendors embed the voice and ambient capabilities inside their own products, an option unique in this pairing.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. DeepScribe and Suki are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | DeepScribe | Suki |
|---|---|---|
| Primary category | Ambient Scribes | Ambient Scribes |
| Founded | 2017 | 2017 |
| Headquarters | San Francisco, California | Redwood City, California |
| Website | deepscribe.ai | suki.ai |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards DeepScribe its top capability grade on several axes, including AI Centrality, Clinical and Operational Evidence and EHR and Interoperability Depth. Set against Suki, DeepScribe grades higher on Clinical and Operational Evidence and Setting and Specialty Coverage. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, July 2026
The AI Health Index awards Suki its top capability grade on AI Centrality and EHR and Interoperability Depth. Set against DeepScribe, Suki grades higher on AI Safety and PHI Stewardship and Security Certifications and Trust Center. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, July 2026
Questions buyers ask
Should we choose DeepScribe or Suki?
On the axes where the AI Health Index separates them, DeepScribe grades higher on Clinical and Operational Evidence and Setting and Specialty Coverage, and Suki grades higher on AI Safety and PHI Stewardship and Security Certifications and Trust Center. Neither leads on the greater share of scored axes, so the decision turns on which constraint is binding rather than on an overall winner.
Where do DeepScribe and Suki differ most?
The widest separation the AI Health Index records between DeepScribe and Suki is on Clinical and Operational Evidence, where DeepScribe grades A and Suki grades C. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do DeepScribe and Suki grade the same?
The AI Health Index grades DeepScribe and Suki the same on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Ambient Scribes page.
Visit volumes and market share figures are vendor published, including DeepScribe's oncology share and Suki's weekly consult count. DeepScribe's KLAS scores are buyer survey based; the Emerging Company Spotlight is a different KLAS instrument from the Best in KLAS category awards held elsewhere in this lane. Suki deletes audio and transcripts after 30 days by default. Neither vendor publishes pricing.